APAC Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of USD 691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.

Highlighted with 92 tables and 68 figures, this 192-page report Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity is based on comprehensive research of the entire Asia Pacific active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Synthetic API

Branded Synthetic API

Generic Synthetic API

Biotech API by Drug Type:

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Other Biotech APIs

Biotech API by Customer Base:

Innovative Biologic API

Generic Biosimilar API

Biotech API by Expression Technology:

Mammalian Expression

Microbial Expression

Yeast Expression

Insect Expression

Other Expression Technologies

HPAPI

Branded HPAPI

Generic HPAPI

Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Captive Manufacturing

Branded Captive API

Generic Captive API

Merchant Manufacturing by Drug Type:

Branded Merchant API

Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

Merchant Synthetic API

Merchant Biotech API

By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Infectious Diseases

Oncology

Ophthalmology

Cardiovascular Disorders

Central Nervous System

Pulmonary Disorders

Orthopedics

Other Applications

By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD bn) for 2018-2028 included in each section.

Branded Prescription Drugs

Generic Prescription Drugs

OTC Drugs

Geographically, the following national/local markets are fully investigated:UK

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue (USD bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AbbVie Inc.

Astrazeneca

Aurobindo Pharma Ltd.

BASF

Bayer AG

Boehringer Ingelheim

Catalent Inc.

Dr. Reddy's Laboratories

F. Hoffmann-La Roche

GlaxoSmithKline plc

Lonza Group

Lupin Limited

Merck & Co., Inc.

Mylan NV

Novartis International AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

AbbVie Inc.

Astrazeneca

Aurobindo Pharma Ltd.

BASF

Bayer AG

Boehringer Ingelheim

Catalent Inc.

Dr. Reddy's Laboratories

F. Hoffmann-La Roche

GlaxoSmithKline plc

Lonza Group

Lupin Limited

Merck & Co., Inc.

Mylan NV

Novartis International AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 31

2.3 Market Restraints and Challenges 39

2.4 Emerging Opportunities and Market Trends 42

2.5 Porter's Fiver Forces Analysis 46

3 Segmentation of Asia Pacific Market by Synthesis 50

3.1 Market Overview by Synthesis 50

3.2 Synthetic API 52

3.2.1 Branded Synthetic API 53

3.2.2 Generic Synthetic API 54

3.3 Biotech API 55

3.3.1 Biotech API by Drug Type 56

3.3.1.1 Monoclonal Antibodies 57

3.3.1.2 Recombinant Proteins 58

3.3.1.3 Vaccines 59

3.3.1.4 Other Biotech APIs 60

3.3.2 Biotech API by Category 61

3.3.2.1 Innovative Biologic API 62

3.3.2.2 Generic Biosimilar API 63

3.3.3 Biotech API by Expression Technology 64

3.3.3.1 Mammalian Expression 65

3.3.3.2 Microbial Expression 66

3.3.3.3 Yeast Expression 67

3.3.3.4 Insect Expression 68

3.3.3.5 Other Expression Technologies 69

3.4 HPAPI 70

3.4.1 Branded HPAPI 71

3.4.2 Generic HPAPI 72

4 Segmentation of Asia Pacific Market by Manufacturing Process 73

4.1 Market Overview by Manufacturing Process 73

4.2 Captive Manufacturing 75

4.2.1 Branded Captive API 76

4.2.2 Generic Captive API 77

4.3 Merchant Manufacturing 78

4.3.1 Merchant Manufacturing by Drug Type 79

4.3.1.1 Branded Merchant API 80

4.3.1.2 Generic Merchant API 81

4.3.2 Merchant Manufacturing by Drug Synthesis 82

4.3.2.1 Merchant Synthetic API 83

4.3.2.2 Merchant Biotech API 84

5 Segmentation of Asia Pacific Market by Therapeutic Application 85

5.1 Market Overview by Therapeutic Application 85

5.2 Infectious Diseases 87

5.3 Oncology 88

5.4 Ophthalmology 89

5.5 Cardiovascular Disorders 90

5.6 Central Nervous System 91

5.7 Pulmonary Disorders 92

5.8 Orthopedics 93

5.9 Other Applications 94

6 Segmentation of Asia Pacific Market by Drug Type 95

6.1 Market Overview by Drug Type 95

6.2 Branded Prescription Drugs 97

6.3 Generic Prescription Drugs 98

6.4 OTC Drugs 99

7 Asia-Pacific Market 2021-2028 by Country 100

7.1 Overview of Asia-Pacific Market 100

7.2 China 103

7.3 Japan 105

7.4 India 108

7.5 Australia 110

7.6 South Korea 112

7.7 Rest of APAC Region 114

8 Competitive Landscape 116

8.1 Overview of Key Vendors 116

8.2 New Product Launch, Partnership, Investment, and M&A 119

8.3 Company Profiles 120

AbbVie Inc. 120

Astrazeneca 122

Aurobindo Pharma Ltd. 127

BASF 130

Bayer AG 133

Boehringer Ingelheim 137

Catalent Inc. 142

Dr. Reddy's Laboratories 145

F. Hoffmann-La Roche 147

GlaxoSmithKline plc 149

Lonza Group 154

Lupin Limited 159

Merck & Co., Inc. 162

Mylan NV 165

Novartis International AG 168

Pfizer Inc. 171

Sanofi 176

Sun Pharmaceutical Industries Ltd. 179

Teva Pharmaceutical Industries Ltd. 182

Thermo Fisher Scientific 184

9 Investing in Asia Pacific Market: Risk Assessment and Management 186

9.1 Risk Evaluation of Asia Pacific Market 186

9.2 Critical Success Factors (CSFs) 189

Related Reports and Products 192


List of Figure

List of Figures:

Figure 1. Research Method Flow Chart 13

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028 18

Figure 4. Asia Pacific Active Pharmaceutical Ingredients (API) Market, 2021-2028, USD bn 21

Figure 5. Impact of COVID-19 on Business 24

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market 31

Figure 7. GDP per capita in the World, 1960-2018, USD thousand 34

Figure 8. Leading Causes of Death in the World, 2019-2020, million 35

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36

Figure 11. Primary Restraints and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market 39

Figure 12. Investment Opportunity Analysis 43

Figure 13. Porter's Fiver Forces Analysis of Asia Pacific Active Pharmaceutical Ingredients (API) Market 46

Figure 14. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue 50

Figure 15. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Synthesis, Value (USD bn) and Share (%) 51

Figure 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, USD bn 52

Figure 17. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, USD bn 53

Figure 18. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, USD bn 54

Figure 19. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, USD bn 55

Figure 20. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, USD bn 57

Figure 21. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, USD bn 58

Figure 22. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, USD bn 59

Figure 23. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, USD bn 60

Figure 24. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, USD bn 62

Figure 25. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, USD bn 63

Figure 26. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, USD bn 65

Figure 27. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, USD bn 66

Figure 28. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, USD bn 67

Figure 29. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, USD bn 68

Figure 30. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, USD bn 69

Figure 31. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, USD bn 70

Figure 32. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, USD bn 71

Figure 33. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, USD bn 72

Figure 34. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue 73

Figure 35. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Manufacturing Process, Value (USD bn) and Share (%) 74

Figure 36. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, USD bn 75

Figure 37. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, USD bn 76

Figure 38. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, USD bn 77

Figure 39. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, USD bn 78

Figure 40. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, USD bn 80

Figure 41. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, USD bn 81

Figure 42. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, USD bn 83

Figure 43. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, USD bn 84

Figure 44. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue 85

Figure 45. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Therapeutic Application, Value (USD bn) and Share (%) 86

Figure 46. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, USD bn 87

Figure 47. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, USD bn 88

Figure 48. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, USD bn 89

Figure 49. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, USD bn 90

Figure 50. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, USD bn 91

Figure 51. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, USD bn 92

Figure 52. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, USD bn 93

Figure 53. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, USD bn 94

Figure 54. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue 95

Figure 55. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Drug Type, Value (USD bn) and Share (%) 96

Figure 56. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, USD bn 97

Figure 57. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, USD bn 98

Figure 58. Asia Pacific Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, USD bn 99

Figure 59. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue 101

Figure 60. Contribution to APAC 2022-2028 Cumulative Revenue by Country, Value (USD bn) and Share (%) 102

Figure 61. Active Pharmaceutical Ingredients (API) Market in China, 2018-2028, USD bn 103

Figure 62. Active Pharmaceutical Ingredients (API) Market in Japan, 2018-2028, USD bn 106

Figure 63. Active Pharmaceutical Ingredients (API) Market in India, 2018-2028, USD bn 108

Figure 64. Active Pharmaceutical Ingredients (API) Market in Australia, 2018-2028, USD bn 110

Figure 65. Active Pharmaceutical Ingredients (API) Market in South Korea, 2018-2028, USD bn 112

Figure 66. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2018-2028, USD bn 114

Figure 67. Growth Stage of Asia Pacific Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 116

Figure 68. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars) 123


List of Table

List of Tables:

Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19

Table 2. World Economic Outlook, 2021-2031 23

Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, USD bn 38

Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market 42

Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 50

Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, USD bn 52

Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, USD bn 56

Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, USD bn 61

Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, USD bn 64

Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, USD bn 70

Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 73

Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, USD bn 75

Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, USD bn 79

Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, USD bn 82

Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 85

Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, USD bn 95

Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, USD bn 101

Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 104

Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 104

Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 104

Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 107

Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 107

Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 107

Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 109

Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 109

Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 109

Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 111

Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 111

Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 111

Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, USD bn 113

Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, USD bn 113

Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, USD bn 113

Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, USD bn 115

Table 34. AbbVie Inc.: Company Snapshot 120

Table 35. AbbVie Inc.: Product Portfolio 120

Table 36. AbbVie Inc.: Revenue, 2018-2020, USD bn 121

Table 37. Astrazeneca: Company Snapshot 122

Table 38. Astrazeneca: Revenue, 2018-2020, USD bn 123

Table 39. Aurobindo Pharma Ltd.: Company Snapshot 127

Table 40. Aurobindo Pharma Ltd.: Product Portfolio 128

Table 41. BASF: Company Snapshot 130

Table 42. BASF: Business Segmentation 131

Table 43. BASF: Revenue by Region 131

Table 44. Bayer AG: Company Snapshot 133

Table 45. Bayer AG: Business Segmentation 134

Table 46. Bayer AG: Revenue, 2018-2020, EUR bn 134

Table 47. Boehringer Ingelheim: Company Snapshot 137

Table 48. Boehringer Ingelheim: Business Segmentation in 2019 138

Table 49. Boehringer Ingelheim: Product Portfolio 138

Table 50. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 139

Table 51. Boehringer Ingelheim: Revenue by Region in 2019 139

Table 52. Catalent Inc.: Company Snapshot 142

Table 53. Catalent Inc.: Business Segmentation in 2018 143

Table 54. Catalent Inc.: Product Portfolio 143

Table 55. Catalent Inc.: Revenue, 2018-2020, USD million 144

Table 56. Catalent Inc.: Revenue by Region in 2018 144

Table 57. Dr. Reddy's Laboratories: Company Snapshot 145

Table 58. Dr. Reddy's Laboratories: Business Segmentation 145

Table 59. Dr. Reddy's Laboratories: Revenue, 2019-2021, USD bn 146

Table 60. F. Hoffmann-La Roche: Company Snapshot 147

Table 61. F. Hoffmann-La Roche: Business Segmentation 148

Table 62. GlaxoSmithKline: Company Snapshot 149

Table 63. GlaxoSmithKline: Business Segmentation 150

Table 64. GlaxoSmithKline: Product Portfolio 151

Table 65. GlaxoSmithKline: Revenue, 2018-2020, USD bn 152

Table 66. Lonza Group: Company Snapshot 154

Table 67. Lonza Group: Business Segmentation in 2018 155

Table 68. Lonza Group: Product Portfolio 155

Table 69. Lonza Group: Revenue by Region in 2018 156

Table 70. Lupin Limited: Company Snapshot 159

Table 71. Lupin Limited: Business Segmentation 159

Table 72. Merck & Co., Inc.: Company Snapshot 162

Table 73. Merck & Co., Inc.: Business Segmentation 162

Table 74. Merck & Co., Inc.: Revenue, 2018-2020, USD bn 163

Table 75. Mylan NV: Company Snapshot 165

Table 76. Mylan NV: Revenue, 2017-2019, USD bn 166

Table 77. Novartis International AG: Company Snapshot 168

Table 78. Novartis International AG: Business Segmentation 168

Table 79. Novartis International AG: Revenue, 2017-2019, USD bn 169

Table 80. Pfizer Inc.: Company Snapshot 171

Table 81. Pfizer Inc.: Business Segmentation 172

Table 82. Pfizer Inc.: Product Portfolio 173

Table 83. Pfizer Inc.: Revenue, 2018-2020, USD bn 173

Table 84. Sanofi: Company Snapshot 176

Table 85. Sanofi: Business Segmentation 176

Table 86. Sanofi: Revenue, 2018-2020, USD bn 177

Table 87. Sun Pharmaceutical Industries Limited: Company Snapshot 179

Table 88. Teva Pharmaceutical Industries Ltd.: Company Snapshot 182

Table 89. Teva Pharmaceutical Industries Ltd.: Business Segmentation 183

Table 90. Thermo Fisher Scientific: Company Snapshot 184

Table 91. Risk Evaluation for Investing in Asia Pacific Market, 2021-2028 187

Table 92. Critical Success Factors and Key Takeaways 190

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert